1-20 of 96
Monica Crugnola
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lifestyle Behaviors and Health-Related Quality of Life in Long-Term Survivors of Acute Myeloid Leukemia: An International Survivorship Study By the Gimema, EORTC Quality of Life and Leukemia Groups

Fabio Efficace, Laura Cannella, Xavier Thomas, Meltem Kurt Yuksel, Silvia Maria Trisolini, Capria Saveria, Alberto Brini, Ernesta Audisio, Luca Maurillo, Roberto Massimo Lemoli, Annalisa Imovilli, Irina Panovska Stavridis, Martina Quattrone, Maria Ciccone, Nunzio Filardi, Nicola Fracchiolla, Daniele Vallisa, Monica Crugnola, Lorella Maria Antonia Melillo, Matevz Skerget, Marco Vignetti, Frederic Baron
Journal: Blood
Blood (2023) 142 (Supplement 1): 3801.
https://doi.org/10.1182/blood-2023-179248
Published: 2023
Journal Articles

Phase Ib/II Study (NCT02488408 / BGBC003) of Bemcentinib Monotherapy or in Combination with Cytarabine or Decitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): FINAL Results

Sonja Loges, Michael Heuser, Jolanta Chromik, Grerk Sutamtewagul, Silke Kapp-Schwoerer, Monica Crugnola, Nicola Di Renzo, Roberto Massimo Lemoli, Daniele Giovanni Mattei, Isabel Ben Batalla, Jonas Waizenegger, Melanie Janning, Lisa-Marie Rieckmann, Charles Imbusch, Niklas Beumer, David Micklam, Claudia Gorcea-Carson, Cristina Oliva, Walter Fiedler, Yesid Alvarado-Valero, Nigel McCracken, Bjorn T. Gjertsen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4287.
https://doi.org/10.1182/blood-2023-181833
Published: 2023
Journal Articles

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Therapy of Acute Myeloid Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata, Benedetta Cambò, Anna Lina Piccioni, Vincenzo Federico, Gianluca Cristiano, Elisabetta Lugli, Lorenzo Rizzo, Michelina Santopietro, Carla Mazzone, Massimiliano Bonifacio, Raffaele Palmieri, Antonella Poloni, Annalisa Biagi, Gianni Binotto, Marzia Delfina, Mario Annunziata, Alfredo Molteni, Monica Piedimonte, Ida Carmosino, Ambra Di Veroli, Pasquale Niscola, Marta Riva, Isabella Capodanno, Antonio Curti, Nicola Di Rienzo, Susanna Fenu, Monica Crugnola
Journal: Blood
Blood (2023) 142 (Supplement 1): 6497.
https://doi.org/10.1182/blood-2023-186085
Published: 2023
Journal Articles

Efficacy of Frontline Treatment with Initial Low-Dose Tyrosine-Kinase Inhibitors in Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study

Cristina Bucelli, Isabella Capodanno, Maria Cristina Miggiano, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Mario Annunziata, Federica SORA, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Imma Attolico, Gianni Binotto, Elena Crisa', Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Rosaria Sancetta, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Alessandra Iurlo, Mario Tiribelli, Roberto Latagliata
Journal: Blood
Blood (2023) 142 (Supplement 1): 3176.
https://doi.org/10.1182/blood-2023-186406
Published: 2023
Journal Articles

Association of Hypomethylating Agents + Venetoclax in the Real-Life Treatment of Myeloproliferative Neoplasms in Blastic Phase

Roberto Latagliata, Gianluca Cristiano, Dorela Lame, Alda Strazimiri, Fabrizio Cavalca, Lorenzo Rizzo, Giulia De Luca, Simone Zoletto, Vincenzo Federico, Daniele Cattaneo, Annalisa Biagi, Monica Crugnola, Pasquale Niscola, Raffaele Palmieri, Anna Lina Piccioni, Olga Mulas, Beatrice Esposito Vangone, Michelina Santopietro, Ida Carmosino, Alessandra Iurlo, Nicola Di Rienzo, Gianni Binotto, Prassede Salutari, Marta Riva, Massimiliano Bonifacio, Elena Maria Elli, Antonio Curti, Antonella Poloni
Journal: Blood
Blood (2023) 142 (Supplement 1): 1842.
https://doi.org/10.1182/blood-2023-190091
Published: 2023
Journal Articles

AML Treatment By the AXL Inhibitor Bemcentinib in Combination with Cytarabine Shows Clinical Efficacy Related to TNFα and Cytotoxic Immune Cells: A Single-Cell Translational Study from the BGBC003 Trial

Niklas Beumer, Jonas S. Waizenegger, Michael Heuser, Jörg Chromik, Grerk Sutamtewagul, Silke Kapp-Schwoerer, Monica Crugnola, Nicola Di Renzo, Roberto M. Lemoli, Daniele G. Mattei, Walter Fiedler, Yesid Alvarado-Valero, David Micklem, Linn H. Nilsson, Noelly Madeleine, Nigel McCracken, Cristina Oliva, Claudia Gorcea-Carson, Lisa-Marie Rieckmann, Jenny Krause, Victoria Gensch, Isabel Ben Batalla, Melanie Janning, Nicola Gagliani, Benedikt Brors, Charles D. Imbusch, Bjorn T. Gjertsen, Sonja Loges
Journal: Blood
Blood (2023) 142 (Supplement 1): 1540.
https://doi.org/10.1182/blood-2023-185499
Published: 2023
Journal Articles

3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients

Michele Malagola, Alessandra Iurlo, Cristina Bucelli, Elisabetta Abruzzese, Massimiliano Bonifacio, Fabio Stagno, Gianni Binotto, Mariella D'Adda, Monia Lunghi, Monica Crugnola, Maria Luisa Ferrari, Francesca Lunghi, Fausto Castagnetti, Gianantonio Rosti, Roberto Massimo Lemoli, Rosaria Sancetta, Maria Rosaria Coppi, Maria Teresa Corsetti, Matteo Dalmazzo, Atelda Romano, Mario Tiribelli, Antonella Russo Rossi, Sabina Russo, Anna Sicuranza, Aldo Roccaro, Giulia Butturini, Mirko Farina, Simona Bernardi, Simone Pellizzeri, Nicola Polverelli, Domenico Russo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3165.
https://doi.org/10.1182/blood-2023-177619
Published: 2023
Journal Articles

Baseline Features, Treatment Choice and Early Frontline TKI Permanent Discontinuation in Younger Patients with Chronic Myeloid Leukemia: A “Campus CML” Study

Francesco Cavazzini, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Atelda Romano, Federica Sorà, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Maria Pia Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Marco Santoro, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Alessandra Iurlo, Mario Tiribelli, Roberto Latagliata
Journal: Blood
Blood (2023) 142 (Supplement 1): 1811.
https://doi.org/10.1182/blood-2023-188934
Published: 2023
Journal Articles

Choice of Tyrosine Kinase Inhibitor and Early Events during the First Year of Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) Patients with Concomitant Diabetes: A "Campus CML" Study

Isabella Capodanno, Mario Tiribelli, Maria Cristina Miggiano, Cristina Bucelli, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Emilia Scalzulli, Andrea Bernardelli, Luigiana Luciano, Olga Mulas, Giuseppina Loglisci, Chiara Elena, Umberto Pizzano, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Annapaola Leporace, Maria Basile, Monica Crugnola, Fabio Stagno, Pamela Murgano, Davide Rapezzi, Debora Luzi, Alessandra Iurlo, Monica Bocchia, Carmen Fava, Alessandra Malato, Sara Galimberti, Iolanda Donatella Vincelli, Malgorzata Monika Trawinska, Michele Pizzuti, Giovanni Caocci, Massimiliano Bonifacio, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Roberto Latagliata
Journal: Blood
Blood (2022) 140 (Supplement 1): 3920–3922.
https://doi.org/10.1182/blood-2022-164790
Published: 2022
Journal Articles

Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study

Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Alessandra Iurlo, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Andrea Bernardelli, Olga Mulas, Chiara Elena, Gianni Binotto, Elena Crisà, Ambra Di Veroli, Anna Rita Scortechini, Maria Basile, Monica Crugnola, Pamela Murgano, Michele Pizzuti, Cristina Bucelli, Carmen Fava, Matteo Dalmazzo, Francesca Lunghi, Giovanni Caocci, Massimiliano Bonifacio, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Mario Tiribelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 3906–3907.
https://doi.org/10.1182/blood-2022-170415
Published: 2022
Journal Articles

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata, Gianluca Cristiano, Dorela Lama, Susanna Fenu, Lorenzo Rizzo, Benedetta Cambò, Simone Zoletto, Francesca Spirito, Fabrizio Cavalca, Daniele Cattaneo, Natalia Cenfra, Giulia De Luca, Beatrice Esposito Vangone, Ambra Di Veroli, Raffaele Palmieri, Mario Annunziata, Olga Mulas, Elisabetta Abruzzese, Alfredo Molteni, Monica Piedimonte, Ida Carmosino, Prassede Salutari, Annalisa Biagi, Monica Bocchia, Michelina Santopietro, Gianni Binotto, Alessandra Iurlo, Monica Crugnola, Marta Riva, Anna Lina Piccioni, Elena Maria Elli, Antonio Curti, Antonella Poloni
Journal: Blood
Blood (2022) 140 (Supplement 1): 6176–6178.
https://doi.org/10.1182/blood-2022-167334
Published: 2022
Journal Articles

Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)

Massimo Breccia, Paola Guglielmelli, Francesco Mendicino, Alessandra Malato, Giuseppe A. Palumbo, Carmine Selleri, Daniela Cilloni, Patrizio Mazza, Sergio Siragusa, Elisabetta Abruzzese, Maurizio Martelli, Giulia Benevolo, Erminia Rinaldi, Monica Crugnola, Serena Rupoli, Vincenzo Pavone, Massimiliano Bonifacio, Fabrizio Pane, Giuseppe Carli, Maria Langella, Marta Bruno Ventre, Elena Maria Elli, Stefana Impera, Anna Marina Liberati, Nicola Di Renzo, Bruno Martino, Paolo Sportoletti, Mario Tiribelli, Gianni Binotto, Mario Annunziata, Mauro Di Ianni, Giorgio La Nasa, Antonietta Pia Falcone, Rossana Leanza, Antonio Volpe, Filippo Gherlinzoni, Valerio De Stefano, Daniele Vallisa, Sabrina Leonetti Crescenzi, Francesco Cavazzini, Alessandra Ricco, Carmela Barberio, Alessandra Misto, Francesco Passamonti, Francesca Palandri
Journal: Blood
Blood (2022) 140 (Supplement 1): 9688–9690.
https://doi.org/10.1182/blood-2022-157914
Published: 2022
Journal Articles

In Search of Drivers of CD34+/CD38-/CD26+ Leukemia Stem Cells Persistence in CML Patients

Paola Pacelli, Elena Bestoso, Anna Sicuranza, Elisabetta Abruzzese, Luigiana Luciano, Alessandra Iurlo, Marzia Defina, Sara Fredducci, Monica Crugnola, Valentina Giai, Federica Sorà, Sara Galimberti, Donatella Raspadori, Monica Bocchia
Journal: Blood
Blood (2022) 140 (Supplement 1): 12171–12172.
https://doi.org/10.1182/blood-2022-169085
Published: 2022
Journal Articles

Bemcentinib (Oral AXL Inhibitor) in Combination with Low-Dose Cytarabine Is Well Tolerated and Efficacious in Older Relapsed AML Patients.Updates from the Ongoing Phase II Trial (NCT02488408) and Preliminary Translational Results Indicating Bemcentinib Elicits Anti-AML Immune Responses

Sonja Loges, Grerk Sutamtewagul, Michael Heuser, Jörg Chromik, Silke Kapp-Schwoerer, Monica Crugnola, Nicola Di Renzo, Roberto M. Lemoli, Daniele Giovanni Mattei, Isabel Ben Batalla, Monica Hellesøy, Jonas Waizenegger, Melanie Janning, Charles D. Imbusch, Niklas Beumer, Austin Rayford, Jaya Nautiyal, Tzivia Berkman-Gottlieb, David Micklem, Hani Gabra, Claudia Gorcea-Carson, James B. Lorens, Walter Fiedler, Yesid Alvarado, Bjorn T. Gjertsen, Lisa-Marie Rieckmann
Journal: Blood
Blood (2021) 138 (Supplement 1): 3410.
https://doi.org/10.1182/blood-2021-147225
Published: 2021
Journal Articles

Efficacy and Safety of Ruxolitinib in the Treatment of Elderly Patients with Policythemia Vera Resistant/Intolerant to Hydroxyurea

Roberto Latagliata, Daniela Bartoletti, Alessandro Andriani, Massimo Breccia, Elena Rossi, Giuseppe Auteri, Florian H. Heidel, Elena Maria Elli, Novella Pugliese, Francesco Mendicino, Giulia Benevolo, Bruno Martino, Alessandra D'Addio, Alessia Tieghi, Ambra Di Veroli, Gianni Binotto, Monica Crugnola, Massimiliano Bonifacio, Giovanni Caocci, Francesco Cavazzini, Mario Tiribelli, Nicola Vianelli, Michele Cavo, Giuseppe A. Palumbo, Valerio De Stefano, Francesca Palandri
Journal: Blood
Blood (2021) 138 (Supplement 1): 2581.
https://doi.org/10.1182/blood-2021-149612
Published: 2021
Journal Articles

Analysis of Early Events during the First Year of Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase - Chronic Myeloid Leukemia: A "Campus CML" Study

Mario Tiribelli, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Emilia Scalzulli, Andrea Bernardelli, Luigiana Luciano, Olga Mulas, Giuseppina Loglisci, Chiara Elena, Umberto Pizzano, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Annapaola Leporace, Maria Basile, Monica Crugnola, Fabio Stagno, Pamela Murgano, Davide Rapezzi, Alessandra Malato, Michele Pizzuti, Debora Luzi, Malgorzata Monika Trawinska, Alessandra Iurlo, Monica Bocchia, Carmen Fava, Giovanni Caocci, Massimiliano Bonifacio, Giuseppe Nicola Saglio, Giorgina Specchia, Massimo Breccia, Roberto Latagliata
Journal: Blood
Blood (2021) 138 (Supplement 1): 1487.
https://doi.org/10.1182/blood-2021-149780
Published: 2021
Journal Articles

Peripheral Blasts Are Associated with Response to Ruxolitinib and Outcome in Patients with Chronic-Phase Myelofibrosis

Francesca Palandri, Daniela Bartoletti, Elisabetta Abruzzese, Alessandra Iurlo, Massimiliano Bonifacio, Giovanni Caocci, Elena Maria Elli, Giuseppe Auteri, Mario Tiribelli, Nicola Polverelli, Bruno Martino, Maurizio Miglino, Florian H. Heidel, Alessia Tieghi, Giulia Benevolo, Eloise Beggiato, Carmen Fava, Francesco Cavazzini, Novella Pugliese, Gianni Binotto, Costanza Bosi, Monica Crugnola, Emanuela Ottaviani, Christian Di Pietro, Giorgia Micucci, Malgorzata Monika Trawinska, Antonio Cuneo, Monica Bocchia, Mauro Krampera, Fabrizio Pane, Roberto M. Lemoli, Daniela Cilloni, Michele Cavo, Nicola Vianelli, Giuseppe A. Palumbo, Massimo Breccia
Journal: Blood
Blood (2021) 138 (Supplement 1): 3624.
https://doi.org/10.1182/blood-2021-152420
Published: 2021
Journal Articles

Choice of Frontline Tyrosine-Kinase Inhibitor in Very Elderly Patients with Chronic Myeloid Leukemia: A "Campus CML" Study

Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Gioia Colafigli, Mario Annunziata, Federica Sora, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Rikard Mullai, Imma Attolico, Gianni Binotto, Elena Crisà, Alessandra Iurlo, Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Annapaola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Rosaria Sancetta, Pamela Murgano, Davide Rapezzi, Debora Luzi, Monica Bocchia, Carmen Fava, Alessandra Malato, Jolanda Donatella Vincelli, Elisabetta Abruzzese, Giuseppe Nicola Saglio, Giorgina Specchia, Massimo Breccia, Mario Tiribelli
Journal: Blood
Blood (2021) 138 (Supplement 1): 3617.
https://doi.org/10.1182/blood-2021-151538
Published: 2021
Journal Articles

Azacitidine and Lenalidomide in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study and Impact of Cytogenetic Scores and Mutational Status on Long-Lasting Responses

Carlo Finelli, Sarah Parisi, MDPhD, Matilde Y Follo, PhD, Cristina Clissa, MD, Miriam Fogli, PhD, Sara Mongiorgi, PhD, Costanza Bosi, MD, Isabella Capodanno, MD, Barbara Castagnari, MD, Anna Candoni, Monica Crugnola, MD, Maria Benedetta Giannini, MD, Giovanna Leonardi, Maurizio Miglino, PhD, Gian Matteo Rigolin, Domenico Russo, MD, Patrizia Tosi, Andrea Pellagatti, Jacqueline Boultwood, Lucio Cocco, MD, Michele Cavo
Journal: Blood
Blood (2020) 136 (Supplement 1): 45.
https://doi.org/10.1182/blood-2020-138371
Published: 2020
Journal Articles

Differential Treatment Strategy in Polycythemia Vera Patients with Stable Suboptimal Response to Hydroxyurea: Clinical Correlations and Impact on Survival

Francesca Palandri, MD PhD, Daniela Bartoletti, MSc, Giulia Benevolo, Massimo Breccia, MD, Elena M Elli, MD, Francesco Cavazzini, MD, Gianni Binotto, MD, Alessia Tieghi, MD, Mario Tiribelli, MD, Florian H. Heidel, MD, Massimiliano Bonifacio, MD, Novella Pugliese, MD, Giovanni Caocci, MD, Monica Crugnola, MD, Francesco Mendicino, MD, Enrica A Martino, MD, Alessandra D'Addio, MD, Simona Tomassetti, MD, Bruno Martino, MD, Giuseppe Auteri, MD, Lucia Catani, PhD, Rossella Stella, MD, Fabio D'Amore, MD, Luigi Scaffidi, MD, Nicola Polverelli, MD, Fabrizio Pane, MD, Antonio Cuneo, MD, Mauro Krampera, MD PhD, Gianpietro Semenzato, MD, Roberto M. Lemoli, Nicola Vianelli, MD, Michele Cavo, Giuseppe A. Palumbo, MD PhD, Roberto Latagliata
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-140001
Published: 2020